Turner Investments’s Pfizer PFE Stock Holding History

Turner Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,238	Closed	-$170K	–	278
2017 Q1	$170K	Sell	5,238 -46,629	-90%	-$1.47M	0.11%	192
2016 Q4	$1.6M	Sell	51,867 -20,437	-28%	-$624K	0.65%	52
2016 Q3	$2.32M	Sell	72,304 -11,753	-14%	-$393K	0.77%	45
2016 Q2	$2.81M	Sell	84,057 -52,457	-38%	-$1.67M	0.88%	38
2016 Q1	$3.84M	Sell	136,514 -136,019	-50%	-$3.89M	1.04%	28
2015 Q4	$8.35M	Buy	272,533 +128,472	+89%	+$4.04M	1.73%	4
2015 Q3	$4.29M	Buy	144,061 +5,175	+4%	+$166K	0.87%	41
2015 Q2	$4.42M	Buy	138,886 +43,193	+45%	+$1.41M	0.81%	35
2015 Q1	$3.16M	Buy	+95,693	New	+$3.04M	0.57%	57
2013 Q4	–	Sell	-336,342	Closed	-$9.17M	–	635
2013 Q3	$9.17M	Buy	+336,342	New	+$9.15M	0.15%	203

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Turner Investments's PFE Position: Q2 2017 in Review

Turner Investments sold out of Pfizer (PFE) in Q2 2017, closing a stake of 5,238 shares — an estimated $170K sold.

Turner Investments first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $9.17M in Q3 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Turner Investments reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Turner Investments sold 5,238 Pfizer shares in Q2 2017, an estimated $170K.
Turner Investments first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
Turner Investments's Pfizer position peaked at $9.17M in Q3 2013.
2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Turner Investments's 13F filing for Q2 2017, filed 4 Aug 2017.